IDERA PHARMACEUTICALS INC - COM NEW (IDRA)

Q3 2016 13F Holders as of 30 Sep 2016

Type / Class
Equity / COM NEW
Total 13F shares
34,558,465
Share change
+35,704
Total reported value
$88,463,348
Put/Call ratio
63%
Price per share
$2.56
Number of holders
78
Value change
+$872,867
Number of buys
44
Number of sells
20

Institutional Holders of IDERA PHARMACEUTICALS INC - COM NEW (IDRA) as of Q3 2016

As of 30 Sep 2016, IDERA PHARMACEUTICALS INC - COM NEW (IDRA) was held by 78 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 34,558,465 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, NATIXIS, JPMORGAN CHASE & CO, BlackRock Institutional Trust Company, N.A., BlackRock Fund Advisors, Broadfin Capital, LLC, STATE STREET CORP, Palo Alto Investors, LLC, and NORTHERN TRUST CORP. This page lists 78 institutional shareholders reporting positions in this security for the Q3 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.